AM

Asar Mohd Khan

Active Director Whole-Time Director DIN 07053840
DIN 07053840 First appointment Dec 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value •••• Premium profile

About Asar Mohd Khan

Data last updated:

Asar Mohd Khan is a Whole-Time Director at Macmillon Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Macmillon Pharmaceuticals Private Limited reported revenue of ₹83.91 Cr (FY 2024).

DIN 07053840
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 20 Dec 2014
Oldest Company Age 38 yrs
Largest company Macmillon Pharmaceuticals Private Limited · ₹83.91 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director20 Dec 20141988₹83.91 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Macmillon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Asar Mohd Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asar Mohd Khan

Asar Mohd Khan currently holds 1 directorship: Macmillon Pharmaceuticals Private Limited (Whole-Time Director, since 20 Dec 2014, revenue ₹83.91 Cr (FY 2024)).

Asar Mohd Khan was first appointed on 20 Dec 2014 as Whole-Time Director at Macmillon Pharmaceuticals Private Limited.

The current boards of Asar Mohd Khan's companies include Naresh Mahajan (Macmillon Pharmaceuticals Private Limited), Sahil Mahajan (Macmillon Pharmaceuticals Private Limited), Satish Kumar (Macmillon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available